Overview

Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Study done in young breast cancer patients to prevent chemotherapy induced ovarian failure
Phase:
Phase 2
Details
Lead Sponsor:
German Breast Group
Treatments:
Goserelin